Pediatricians' perspectives on COVID-19 and HPV vaccine hesitancy.
Adolescent
Child
Humans
COVID-19 Vaccines
COVID-19
/ prevention & control
Cross-Sectional Studies
Pandemics
/ prevention & control
Papillomavirus Infections
/ prevention & control
Vaccination Hesitancy
Human Papillomavirus Viruses
Papillomavirus Vaccines
Parents
Pediatricians
Vaccination
Health Knowledge, Attitudes, Practice
COVID-19 vaccination
HPV vaccination
Vaccine hesitancy
pediatric providers
survey research
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
01 Aug 2023
01 Aug 2023
Historique:
medline:
26
6
2023
pubmed:
22
6
2023
entrez:
22
6
2023
Statut:
ppublish
Résumé
Rises in parental vaccine hesitancy, observed during the COVID-19 pandemic, threaten public health. This is especially concerning for vaccines not typically required for school-entry, such as the vaccines for COVID-19 and human papillomavirus (HPV), both of which also have much lower rates of completion compared to other adolescent vaccines. Pediatricians are well-positioned to address vaccine hesitancy and can offer insights into parents' perspectives in this area. There is evidence that pediatricians' sharing their own vaccine stories may help to address parents' concerns; yet we have little information on pediatricians' or their children's COVID-19 vaccine uptake. To address these gaps, we conducted a cross-sectional survey about Massachusetts pediatricians' behaviors and perspectives on vaccines that face significant resistance: HPV and COVID-19 vaccines. A total of 144 people initiated the survey, and 109 participants were eligible and completed the survey. Participants reported high levels of COVID-19 vaccine uptake for themselves (97%) and their children (98%). Similarities in parents' resistance toward both vaccines were identified: fear of side effects; general vaccine resistance. Pediatricians reported a rise in vaccine hesitancy since the beginning of the COVID-19 pandemic. Future research should focus on identifying strategies to build overall vaccine confidence and streamline these efforts for pediatricians.
Identifiants
pubmed: 37347712
doi: 10.1080/21645515.2023.2225388
pmc: PMC10288893
doi:
Substances chimiques
COVID-19 Vaccines
0
Papillomavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2225388Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL150341
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA172009
Pays : United States
Références
Pediatrics. 2016 Sep;138(3):
pubmed: 27573088
J Pediatr Health Care. 2014 Nov-Dec;28(6):541-9
pubmed: 25017939
Eval Health Prof. 2007 Dec;30(4):303-21
pubmed: 17986667
Hum Vaccin Immunother. 2020 Nov 1;16(11):2736-2743
pubmed: 32401592
Clin Pediatr (Phila). 2019 Jun;58(6):691-695
pubmed: 30516063
Pediatrics. 2016 Feb;137(2):e20152488
pubmed: 26729738
MMWR Morb Mortal Wkly Rep. 2021 Jul 16;70(28):997-1003
pubmed: 34264908
Patient Educ Couns. 2023 Jan;106:107-112
pubmed: 36244947
Hum Vaccin Immunother. 2016 Jun 2;12(6):1454-68
pubmed: 26838681
Vaccine. 2015 Nov 27;33(48):6629-34
pubmed: 26529071
Hum Vaccin Immunother. 2021 Jul 3;17(7):1961-1967
pubmed: 33439768
MMWR Morb Mortal Wkly Rep. 2022 Sep 02;71(35):1101-1108
pubmed: 36048724
Vaccine. 2020 Aug 27;38(38):6027-6037
pubmed: 32758380
J Community Health. 2022 Feb;47(1):39-52
pubmed: 34297272
Vaccine X. 2022 Oct 19;12:100231
pubmed: 36337836
Hum Vaccin Immunother. 2019;15(7-8):1776-1783
pubmed: 30570419
Vaccine. 2022 Nov 28;40(50):7262-7269
pubmed: 36333226
J Adolesc Health. 2022 Mar;70(3):359-360
pubmed: 35183319
J Pediatr Health Care. 2023 May-Jun;37(3):244-252
pubmed: 36470798
Acad Pediatr. 2018 Mar;18(2):145-153
pubmed: 28754504